2m 2m 2m 2m 2m 2m 2m
Exozymes (EXOZ)
NASDAQ
$6.05+$0.28 (+4.85%)
Price as of Oct 02, 2026 4:10 PM EDT- $53.7MMarket Cap
- -56.62%1-Year Change
- BiotechnologyIndustry
Exozymes (EXOZ)
$6.05+$0.28 (+4.85%)
EXOZ | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.77 | ||
Change | +$0.010 (+0.17%) | ||
Open | $5.87 | ||
High | $6.00 | ||
Low | $5.76 | ||
Previous Close | $5.76 | ||
Volume | 2,116 | ||
30-Day Average Volume | 7,521 | ||
1-Week Change | -7.61% | ||
1-Month Change | -15.02% | ||
1-Year Change | -56.62% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 9.3M | ||
Total Assets | $8.0M | ||
Market Cap | $53.7M | ||
Enterprise Value | $48.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$1.6M | ||
EBIT | $0.00 | ||
EBITDA | $76,949.00 | ||
Net Working Capital | $4.6M | ||
EPS | -$0.33 | ||
Enterprise Value/EBITDA | 624 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 15 | ||
P/E | -17 | ||
PEG | 1 | ||
Price/Free Cash Flow | -33 | ||
Price/Operating Cash Flow | -33 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue